One-Step Synthesis of Nanoliposomal Copper Diethyldithiocarbamate and Its Assessment for Cancer Therapy
The metal complex copper diethyldithiocarbamate (CuET) induces cancer cell death by inhibiting protein degradation and induces proteotoxic stress, making CuET a promising cancer therapeutic. However, no clinical formulation of CuET exists to date as the drug is insoluble in water and exhibits poor b...
Main Authors: | Radu A. Paun, Daciana C. Dumut, Amanda Centorame, Thusanth Thuraisingam, Marian Hajduch, Martin Mistrik, Petr Dzubak, Juan B. De Sanctis, Danuta Radzioch, Maryam Tabrizian |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-03-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/14/3/640 |
Similar Items
-
Development of Liposomal Formulations of Zinc Diethyldithiocarbamate for Colorectal Cancer Treatment
by: Niusha Ansari-Fard, et al.
Published: (2022-11-01) -
Development and optimization of an injectable formulation of copper diethyldithiocarbamate, an active anticancer agent
by: Wehbe M, et al.
Published: (2017-05-01) -
In vitro characterization and in vivo performance of mefenamic acid-sodium diethyldithiocarbamate based liposomes
by: Qais Bashir Jarrar, et al.
Published: (2019-11-01) -
Estimation of arsenic in nail using silver diethyldithiocarbamate method
by: Habiba Akhter Bhuiyan, et al.
Published: (2015-07-01) -
In vitro and in vivo evaluation of diethyldithiocarbamate with copper ions and its liposomal formulation for the treatment of Staphylococcus aureus and Staphylococcus epidermidis biofilms
by: Laurine Kaul, et al.
Published: (2023-12-01)